CAH vs LLY · P/E 35, rev $254.25B vs P/E 39, rev $22.97B
Cardinal Health Inc (CAH) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the CAH and LLY stock pages for the full models.
Not investment advice.